Tetrahydropyridine 3,4-diol derivative, estrogen receptor simulator, drug synthesis, including the manufacture of medicinal components and their use in CCER treatment. PCT
WANG XIAOJING,GOODACRE SIMON CHARLES,LABADIE SHARADA,LIANG JUN,ORTWINE DANIEL FRED,RAY NICHOLAS CHARLES,ZBIEG JASON,ZHANG BIRONG
申请号：
CL2017000814
公开号：
CL2017000814A1
申请日:
2017.04.04
申请国别(地区):
CL
年份:
2017
代理人:
摘要：
<； p >； - tetrahydro compounds are described pirido [3,4-b] indole - 1 - ilo activity or function with Bertalanffy Modulation & amp； n of receptors & acute； Gene Modulation Bertalanffy, having the structure of Formula 1, F & amp； and estereois & amp； Taut & acute； groupers, groupers or Pharmaceutical Salts & eacute； uticame Nte acceptable thereof,With the substituents and character & amp； structural features described here & nbsp；.Also described are Pharmaceutical compositions & eacute； n & eacute； Treatment and medicines that include compounds of Formula 1, F & amp； ACE & amp； M & eacute； all use of such receptors modulators & acute； estrogens alone or in combination, Bertalanffy with other therapeutic agents cosmeceuticals, & eacute；To treat diseases or Pathological States, that & acute； s est & aacute； n Mid or dependent receptors & amp； genos. <； / p >；LA SOLICITUD SE REFIERE A COMPUESTOS DERIVADOS DE TETRAHIDRO-PIRIDO3,4-BINDOL, MODULADORES DE RECEPTORES DE ESTRÓGENOS , A UNA COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE, A UN PROCESO DE FABRICACIÓN DE LA COMPOSICIÓN, A UN KIT FARMACÉUTICO Y A SU USO EN EL TRATAMIENTO DEL CÁNCER.
